GlycoMimetics Inc (GLYC) — Cash Flow-to-Debt Ratio
GlycoMimetics Inc (GLYC) has a Cash Flow-to-Debt Ratio of -1.95x as of March 2025, meaning its operating cash flow of $-5.11 Billion could theoretically repay -2% of its total liabilities ($2.62 Billion) in one year. See how much free cash does GlycoMimetics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlycoMimetics Inc Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for GlycoMimetics Inc across 14 annual periods. Also explore GlycoMimetics Inc (GLYC) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GlycoMimetics Inc (2011–2024)
Year-by-year debt coverage analysis for GlycoMimetics Inc. For market capitalisation and broader financial context, see GLYC market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.38x | $-31.10 Million | $5.78 Million | ▼ -6.5% |
| 2023 | -5.05x | $-34.88 Million | $6.90 Million | ▲ +3.4% |
| 2022 | -5.23x | $-46.46 Million | $8.88 Million | ▼ -16.0% |
| 2021 | -4.51x | $-57.49 Million | $12.74 Million | ▼ -68.0% |
| 2020 | -2.69x | $-39.24 Million | $14.61 Million | ▲ +28.9% |
| 2019 | -3.78x | $-51.98 Million | $13.77 Million | ▲ +18.3% |
| 2018 | -4.62x | $-43.33 Million | $9.38 Million | ▼ -37.9% |
| 2017 | -3.35x | $-29.77 Million | $8.88 Million | ▲ +20.1% |
| 2016 | -4.20x | $-29.73 Million | $7.09 Million | ▼ -306.7% |
| 2015 | -1.03x | $-8.24 Million | $7.99 Million | ▼ -55.6% |
| 2014 | -0.66x | $-4.28 Million | $6.46 Million | ▲ +89.9% |
| 2013 | -6.54x | $-15.54 Million | $2.38 Million | ▼ -267.9% |
| 2012 | -1.78x | $-10.47 Million | $5.89 Million | ▼ -362.5% |
| 2011 | 0.68x | $13.85 Million | $20.45 Million | — |